KR101411124B1 - 헤테로시클릭 유도체의 제조 방법 - Google Patents

헤테로시클릭 유도체의 제조 방법 Download PDF

Info

Publication number
KR101411124B1
KR101411124B1 KR1020087026730A KR20087026730A KR101411124B1 KR 101411124 B1 KR101411124 B1 KR 101411124B1 KR 1020087026730 A KR1020087026730 A KR 1020087026730A KR 20087026730 A KR20087026730 A KR 20087026730A KR 101411124 B1 KR101411124 B1 KR 101411124B1
Authority
KR
South Korea
Prior art keywords
alkyl
methyl
substituted
formula
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020087026730A
Other languages
English (en)
Korean (ko)
Other versions
KR20080108328A (ko
Inventor
세르지오 바치
Original Assignee
글락소 그룹 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 글락소 그룹 리미티드 filed Critical 글락소 그룹 리미티드
Publication of KR20080108328A publication Critical patent/KR20080108328A/ko
Application granted granted Critical
Publication of KR101411124B1 publication Critical patent/KR101411124B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
KR1020087026730A 2006-04-03 2007-03-30 헤테로시클릭 유도체의 제조 방법 Expired - Fee Related KR101411124B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0607899.2A GB0607899D0 (en) 2006-04-03 2006-04-03 Process for preparing heterocyclic derivatives
GB0607899.2 2006-04-03
PCT/EP2007/053118 WO2007113261A1 (en) 2006-04-03 2007-03-30 Process for preparing heterocyclic derivatives

Publications (2)

Publication Number Publication Date
KR20080108328A KR20080108328A (ko) 2008-12-12
KR101411124B1 true KR101411124B1 (ko) 2014-06-25

Family

ID=36581002

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087026730A Expired - Fee Related KR101411124B1 (ko) 2006-04-03 2007-03-30 헤테로시클릭 유도체의 제조 방법

Country Status (18)

Country Link
US (2) US20070232808A1 (enExample)
EP (1) EP2007747B1 (enExample)
JP (1) JP5167242B2 (enExample)
KR (1) KR101411124B1 (enExample)
CN (1) CN101454308B (enExample)
AU (1) AU2007233744B2 (enExample)
BR (1) BRPI0710049A2 (enExample)
CA (1) CA2648089A1 (enExample)
CR (1) CR10351A (enExample)
EA (1) EA017304B1 (enExample)
ES (1) ES2443219T3 (enExample)
GB (1) GB0607899D0 (enExample)
IL (1) IL194389A0 (enExample)
MA (1) MA30354B1 (enExample)
MX (1) MX2008012876A (enExample)
NO (1) NO20084414L (enExample)
WO (1) WO2007113261A1 (enExample)
ZA (1) ZA200808107B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3995C2 (ro) * 2009-05-11 2010-07-31 Государственный Университет Молд0 Utilizare a di(µ-Ofenoxi)-di{[2-(4-aminobenzensulfamido)-5-etil-1,3,4-tiadiazol]-3,5-dibromosalicilidentiosemicarbazonato(-1)-cupru} în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar
IT201700041723A1 (it) 2017-04-14 2018-10-14 Italfarmaco Spa Nuovi inibitori selettivi di HDAC6
CN106866657A (zh) * 2017-04-25 2017-06-20 成都倍特药业有限公司 一种麦角新碱的制备方法
US9862675B1 (en) 2017-07-05 2018-01-09 King Fahd University Of Petroleum And Minerals Method of N-formylating amines with a phosphonic anhydride
JP2023537052A (ja) 2020-08-07 2023-08-30 イタルファルマコ ソシエタ ペル アチオニ 新規オキサジアゾール系の選択的ｈｄａｃ６阻害剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032238A2 (de) * 2000-10-20 2002-04-25 Messmer, Ludwig Hochverdichteter filter tow ballen
WO2005080382A1 (en) 2004-02-23 2005-09-01 Glaxo Group Limited Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020032238A1 (en) * 2000-07-08 2002-03-14 Henning Priepke Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
DE10033337A1 (de) * 2000-07-08 2002-01-17 Boehringer Ingelheim Pharma Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
GB0517193D0 (en) 2005-08-22 2005-09-28 Glaxo Group Ltd Novel use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032238A2 (de) * 2000-10-20 2002-04-25 Messmer, Ludwig Hochverdichteter filter tow ballen
WO2005080382A1 (en) 2004-02-23 2005-09-01 Glaxo Group Limited Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors

Also Published As

Publication number Publication date
CN101454308B (zh) 2013-05-08
JP5167242B2 (ja) 2013-03-21
US20100048895A1 (en) 2010-02-25
US20070232808A1 (en) 2007-10-04
CN101454308A (zh) 2009-06-10
JP2009532428A (ja) 2009-09-10
EP2007747B1 (en) 2013-11-20
AU2007233744B2 (en) 2012-09-06
EP2007747A1 (en) 2008-12-31
WO2007113261A1 (en) 2007-10-11
CA2648089A1 (en) 2007-10-11
BRPI0710049A2 (pt) 2011-08-02
AU2007233744A1 (en) 2007-10-11
IL194389A0 (en) 2009-08-03
EA200870405A1 (ru) 2009-04-28
NO20084414L (no) 2008-10-28
KR20080108328A (ko) 2008-12-12
GB0607899D0 (en) 2006-05-31
US7838680B2 (en) 2010-11-23
MX2008012876A (es) 2008-10-13
EA017304B1 (ru) 2012-11-30
CR10351A (es) 2008-10-29
MA30354B1 (fr) 2009-04-01
ZA200808107B (en) 2009-10-28
ES2443219T3 (es) 2014-02-18

Similar Documents

Publication Publication Date Title
JP7001614B2 (ja) リガンド依存性の標的タンパク質分解のための単官能性中間体
JP6281952B2 (ja) Ｈｉｖ複製阻害剤
EP3704106B1 (en) Alkene compounds as farnesoid x receptor modulators
JP6358639B2 (ja) ６員複素環誘導体およびそれらを含有する医薬組成物
CN113874074A (zh) Hmox1诱导剂
AU2014217453A1 (en) Heterocyclic amides as kinase inhibitors
KR101411124B1 (ko) 헤테로시클릭 유도체의 제조 방법
JP2022535577A (ja) 癌を処置するためのｐｒｃ２阻害剤としてのイミダゾ［１，２－ｃ］ピリミジン誘導体
JP7311944B2 (ja) 二環性含窒素複素環誘導体を含有する医薬組成物
JPWO2018074390A1 (ja) 二環性含窒素複素環誘導体およびそれらを含有する医薬組成物
WO2008085117A1 (en) Pyridine compounds and their use as p2y12 antagonists.
WO2015147247A1 (ja) Ｈｉｖ複製阻害作用を有する３環性誘導体
WO2013050341A1 (en) Azabenzoxazine derivatives as crac modulators
AU2009326909B2 (en) Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
WO2013050270A1 (en) Benzoxazine derivatives as crac modulators
JP6692113B2 (ja) ６員複素環誘導体を含有する医薬組成物
EA043605B1 (ru) Ингибиторы prc2
BR112016000792B1 (pt) Compostos cianotriazol, seu uso, e agente profilático e/ou terapêutico

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20170618

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20170618

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000